Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus

about

Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus

Item

http://www.wikidata.org/entity/Q58588970

description

scientific article published on 19 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Analysis of urinary macrophage ...... n systemic lupus erythematosus

@en

Analysis of urinary macrophage ...... n systemic lupus erythematosus

@nl

type

Item

label

Analysis of urinary macrophage ...... n systemic lupus erythematosus

@en

Analysis of urinary macrophage ...... n systemic lupus erythematosus

@nl

prefLabel

Analysis of urinary macrophage ...... n systemic lupus erythematosus

@en

Analysis of urinary macrophage ...... n systemic lupus erythematosus

@nl

P1476

Analysis of urinary macrophage ...... n systemic lupus erythematosus

@en

P2093

Alberta Y Hoi

http://www.w3.org/2001/XMLSchema#string

Fabienne Mackay

http://www.w3.org/2001/XMLSchema#string

Laura Slavin

http://www.w3.org/2001/XMLSchema#string

P2860

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus

The 1982 revised criteria for the classification of systemic lupus erythematosus

The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Clinical associations of serum interleukin-17 in systemic lupus erythematosus.

A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.

Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.

De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.

Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis.

Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus.

P304

e000277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/LUPUS-2018-000277

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rangi Kandane-rathnayake

P577

2018-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30397495

http://www.w3.org/2001/XMLSchema#string

P921

macrophage

P932

6203042

http://www.w3.org/2001/XMLSchema#string